Letter to the editor regarding the article "pregnancy-associated breast cancer: a multicenter study comparing clinicopathological factors, diagnosis, and treatment outcomes with non-pregnant patients".

Szczegóły
Comments

Tytuł:: Letter to the editor regarding the article "pregnancy-associated breast cancer: a multicenter study comparing clinicopathological factors, diagnosis, and treatment outcomes with non-pregnant patients".
Autorzy:: Sajjadi E; European Institute of Oncology IRCCS, 20141, Milan, Italy.; University of Milan, 20122, Milan, Italy.
Venetis K; European Institute of Oncology IRCCS, 20141, Milan, Italy.
Fusco N; European Institute of Oncology IRCCS, 20141, Milan, Italy. .; University of Milan, 20122, Milan, Italy. .
Źródło:: Breast cancer research and treatment [Breast Cancer Res Treat] 2023 Jun; Vol. 199 (3), pp. 587-588. Date of Electronic Publication: 2023 Apr 19.
Typ publikacji:: Multicenter Study; Letter; Comment
Język:: English
Imprint Name(s):: Publication: Dordrecht : Kluwer Academic
Original Publication: The Hague ; Boston : M. Nijhoff, c1981-
MeSH Terms:: Breast Neoplasms*/diagnosis
Breast Neoplasms*/epidemiology
Breast Neoplasms*/therapy
Pregnancy Complications, Neoplastic*/diagnosis
Pregnancy Complications, Neoplastic*/therapy
Female ; Pregnancy ; Humans ; Treatment Outcome
References:: Tan QT, Alcantara VS, Sultana R, Loh KW, Go AL, Wong FY (2023) Pregnancy-associated breast cancer: a multicenter study comparing clinicopathological factors, diagnosis and treatment outcomes with non-pregnant patients. Breast Cancer Res Treat 198(1):53–66. (PMID: 10.1007/s10549-022-06855-236617357)
Sajjadi E, Venetis K, Noale M, Azim HA Jr, Blundo C, Bonizzi G et al (2022) Breast cancer during pregnancy as a special type of early-onset breast cancer: analysis of the tumor immune microenvironment and risk profiles. Cells 11(15):2286. (PMID: 10.3390/cells11152286358925839332147)
Amant F, Lefrère H, Borges VF, Cardonick E, Lambertini M, Loibl S et al (2021) The definition of pregnancy-associated breast cancer is outdated and should no longer be used. Lancet Oncol 22(6):753–754. (PMID: 10.1016/S1470-2045(21)00183-2340871228868503)
Entry Date(s):: Date Created: 20230419 Date Completed: 20230515 Latest Revision: 20230515
Update Code:: 20240105
DOI:: 10.1007/s10549-023-06951-x
PMID:: 37074482
: Raport

Full Text Finder

Comment on: Breast Cancer Res Treat. 2023 Feb;198(1):53-66. (PMID: 36617357)

Informacja